Viewing Study NCT06231966


Ignite Creation Date: 2025-12-24 @ 4:19 PM
Ignite Modification Date: 2026-01-25 @ 5:10 AM
Study NCT ID: NCT06231966
Status: RECRUITING
Last Update Posted: 2025-05-20
First Post: 2023-12-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Randomized Comparison of Efficacy and Safety of High-intensity Rosuvastatin/Ezetimibe Combination Versus Treat-to-target Rosuvastatin Monotherapy for Patients With Peripheral Artery or Polyvascular Disease (CARE-PVD Trial)
Sponsor: Yonsei University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module